S. Mody

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

S. Horton, M. Gianfrancesco, J. Yazdany, 2022, The Lancet Rheumatology.

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

S. Horton, M. Gianfrancesco, J. Yazdany, 2021, The Lancet Rheumatology.

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study*

S. Mody, J. Schein, A. Fisher, 2009 .